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Abstract
Background Thoracic epidural analgesia (TEA) provides
superior analgesia with a lower incidence of postoperative
ileus when compared with systemic opiate analgesia in
open colorectal surgery. However, in laparoscopic colo-
rectal surgery the role of TEA is not well defined. This
prospective observational study investigates the influence
of TEA in laparoscopic colorectal resections.
Methods All patients undergoing colorectal resection
between November 2004 and February 2007 were assessed
for inclusion into a prospective randomized trial investi-
gating the influence of bisacodyl on postoperative ileus. All
patients treated by laparoscopic resection from this col-
lective were eligible for the present study. Primary
endpoints were use of analgesics and visual analogue scale
(VAS) pain scores. Secondary endpoint concerned full
gastrointestinal recovery, defined as the mean time to the
occurrence of the following three events (GI-3): first flatus
passed, first defecation, and first solid food tolerated.
Results 75 patients underwent laparoscopic colorectal
resection, 39 in the TEA group and 36 in the non-TEA
group. Patients with TEA required significantly less anal-
gesics (metamizol median 3.0 g [0–32 g] versus 13.8 g [0–
28 g] (p \ 0.001); opioids mean 12 mg [±2.8 mg standard
error of mean, SEM] versus 103 mg [±18.2 mg SEM]
(p \ 0.001). VAS scores were significantly lower in the
TEA group (overall mean 1.67 [± 0.2 SEM] versus 2.58
[±0.2 SEM]; p = 0.004). Mean time to gastrointestinal
recovery (GI-3) was significantly shorter (2.96 [±0.2 SEM]
days versus 3.81 [±0.3 SEM] days; p = 0.025). Analysis
of the subgroup of patients with laparoscopically com-
pleted resections showed corresponding results.
Conclusion TEA provides a significant benefit in terms of
less analgesic consumption, better postoperative pain
relief, and faster recovery of gastrointestinal function in
patients undergoing laparoscopic colorectal resection.
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In patients undergoing major open abdominal surgery,
including open colorectal resection, thoracic epidural
analgesia (TEA) provides superior analgesia and reduced
duration of postoperative ileus when compared with sys-
temic opioid analgesia [1–6].
TEA is currently used in multimodal recovery programs,
in combination with early and enhanced feeding, early
removal of drains and catheters, and enforced mobilization
[7]. However, the benefit of TEA itself remains to be
defined. Some authors consider TEA to be the most decisive
intervention in reducing postoperative ileus, whilst others
report no advantage over patient controlled intravenous
opioid analgesia for patients undergoing laparotomy in an
enhanced recovery program [8–10].
Laparoscopic colorectal surgery has gained wide
acceptance; it is associated with reduced surgical trauma,
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less pain, quicker recovery, and shorter hospital stays [11–
13]. Some authors question the benefits of laparoscopic
surgery in a fast-track setting [14–16]. Especially the role of
TEA in laparoscopic colorectal resection has yet not been
defined. Some authors have shown that TEA is beneficial
for pain relief, dietary intake, and length of hospital stay,
but these findings are not consistently reproducible [17–20].
The aim of this prospective observational study was to
investigate the influence of TEA compared to systemic
opioid analgesia on postoperative pain relief and duration
of ileus in patients undergoing elective laparoscopic colo-
rectal resection.
Patients and methods
Patients
Between November 2004 and February 2007, all patients
with elective open or laparoscopic colorectal resections at
the Triemli Hospital in Zurich, Switzerland, were assessed
for eligibility to be included in a prospective, randomized
trial investigating the effect of bisacodyl versus placebo
(trial submitted for publication). The trial was registered by
the National Library of Medicine at www.clinicaltrials.gov
under the number NCT00509327 and was approved by the
local ethics committee. The subgroup of patients with
planned laparoscopic resections was eligible for the present
observational study. A subanalysis excluding all converted
cases to evaluate the collective with laparoscopically
completed resections was additionally performed. There
was no difference in bisacodyl use between the TEA and
non-TEA groups.
Thoracic epidural analgesia
Thoracic epidural analgesia was considered for every
patient. Contraindications were previous back surgery,
severe spondylarthrosis, coagulopathy or patient refusal. In
the TEA group, before induction of general anesthesia, a
thoracic epidural catheter (Espocan 18-G, Braun, Mels-
ungen, Germany) was positioned using the loss-of-
resistance technique between Th8 and Th12. An intrathecal
position was excluded by a bolus injection of 3 ml lidocaine
2% (Rapidocain; Sintetica, Mendrisio, Switzerland).
Ropivacaine 0.3% (Naropin; AstraZeneca, Zug, Switzer-
land) was then administered continuously at 6–12 ml/h
during surgery. Postoperatively, the thoracic epidural cath-
eter was left in situ and a solution consisting of 48 ml
0.125% bupivacaine (Duracain, Sintetica, Mendrisio,
Switzerland) with 2 ml fentanyl (Fentanyl-Curamed, O-
popharma, Zurich, Switzerland), was administered for
continuous analgesia during the first five postoperative days.
Surgical and anesthetic procedure
All patients received standardized bowel preparation (2 l
sodium sulfate/macrogol solution; Cololyt, Spirig Pharma,
Egerkingen, Switzerland). During induction of anesthesia,
all patients received preoperative single-shot antibiotics
(cefuroxime 1.5 g and metronidazole 1 g intravenously).
General anaesthesia with endotracheal intubation was per-
formed using a standard technique with propofol
(Disoprivan, AstraZeneca, Zug, Switzerland), fentanyl
(Fentanyl-Curamed, Opopharma, Zurich, Switzerland),
sevoflurane (Sevorane, Abbott, Baar, Switzerland), and
rocuronium (Esmeron, Organon, Pfa¨ffikon, Switzerland).
Laparoscopic surgery was performed with a four-port
technique with removal of the specimen through a small
transverse incision in the lower abdomen. For left-sided
colectomy, medial mobilization including visualization of
the ureter was used. The anastomosis was performed using a
double stapling technique with a circular end-to-end anas-
tomotic stapler (Premium Plus CEEATM 31 mm, Tyco
Healthcare, Switzerland). In right-sided colectomy, the
colon was also mobilized medially. Resection and anasto-
mosis were performed extracorporally via a transverse
incision in the middle right abdomen with an end-to-end,
single-layer running suture (BiosynTM 4.0, Tyco Health-
care, Switzerland). The nasogastric tube (NGT) was
routinely removed at the end of the anesthesia.
Postoperative regimen
All patients received a basic analgesia of 0.5–1 g oral
paracetamol (Dafalgan, Bristol-Myers Squibb, Baar,
Switzerland) every 6 hours. For additional pain relief
metamizol (Novalgin, Sanofi-Aventis, Meyrin, Switzer-
land) was used as first-line reserve and morphine or its
derivates as second-line reserve. Patient-controlled anal-
gesia (PCA) with intravenous morphine was considered for
a minority of patients. TEA was checked every day by the
anesthetic pain service and removed on postoperative day
five. Nutrition was started on the first postoperative day.
We used a five-step diet protocol, starting with limited
fluids (1000 ml/day), followed by free fluids, soft food,
light meals, and normal diet. Progress to the next step
required bowel movement, absence of nausea, and tolera-
tion of the previously given nutrition.
Data analysis
Primary endpoints were consumption of analgesics and
visual analogue scale (VAS) pain scores during the first
eight postoperative days. To allow comparison, all opioids
were converted to an equivalent morphine dose. The daily
quantity of PCA-administered morphine was recorded and
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added to the on-demand quantity of morphine. VAS scores
were assessed during the morning ward rounds by the
responsible intern. Secondary endpoint was recovery of
gastrointestinal function, defined as the mean time to the
occurrence of the following three events (GI-3): first flatus
passed, first defecation, and first solid food tolerated. Fur-
thermore, frequency of NGT reinsertion, frequency of
postoperative vomiting, and length of hospital stay were
monitored. Other variables recorded were patient demo-
graphics, administration of laxatives (bisacodyl), morbidity
of TEA, and surgical and medical morbidity.
Statistical analysis
Data are shown as median [range] or mean [standard error
of mean, SEM], as appropriate. The qualitative data were
compared statistically using the Fisher’s exact test. If the
quantitative data showed normal distribution parameters,
they were compared parametrically using a paired Stu-
dent’s t-test, else the Mann–Whitney U-test was applied.
Regardless of the statistical tests selected, the level of
significance was defined as p B 0.05 (GraphPad InStat,
GraphPad Software, Inc., San Diego, CA).
Results
Two hundred patients with elective colorectal resection
were enrolled into the prospective, randomized trial on the
effect of bisacodyl versus placebo (NCT00509327). Thirty-
one patients discontinued the study. Seventy-five patients
underwent laparoscopic resection and were eligible for this
prospective observational study (Fig. 1). In 15 patients the
operation was converted to open resection. No significant
difference between groups in demographic characteristics
was noted (Table 1). The majority of patients underwent
rectosigmoid resection (n = 65, 85.3%). Primary indica-
tion was diverticular disease (n = 63, 84%).
With the exception of paracetamol (TEA mean 19.7 g
[±1.5 g] versus 15.6 g [±1.7 g]; p = 0.074), patients with
TEA required significantly less metamizol (median 3.0 g
[0–32 g] versus 13.8 g [0–28 g]; p \ 0.001) or opioids
(mean 12 mg [±2.8 mg] versus 103 mg [±18.2 mg],
p \ 0.001) during the first eight postoperative days. To
assess the opioid consumption during TEA and after
removal, days 1–4 and 5–8 were analyzed separately.
During the first 4 days, opioid consumption was signifi-
cantly lower in the TEA group whereas during days 5–8,
after TEA removal, the difference was no longer significant
(Table 2). In patients with TEA, the quantity of opioids
needed did not increase after removal (days 1–4: mean
6.6 mg [±1.8 mg], days 5–8: mean 5.6 mg [±1.5 mg];
p = 0.684) whereas in the non-TEA group a significant
decrease after 4 days was seen (days 1–4: mean 83.9 mg
[±13.8 mg], days 5–8: mean 17.6 mg [±8.3 mg];
p \ 0.001).
Overall VAS pain scores during the first eight days were
significantly lower in the TEA group (mean 1.67 [±0.2]
versus 2.58 [±0.2]; p = 0.004). Daily VAS pain scores are
shown in Fig. 2.
Recovery of gastrointestinal function (GI-3) occurred
significantly earlier in patients with TEA (2.96 [±0.2] days
versus 3.81 [±0.3] days; p = 0.025). Of the single
parameters defining GI-3, a significant difference was
Fig. 1 Study design
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observed in time to first stool (mean 2.9 [±0.3] days versus
3.8 [±0.3] days; p = 0.038). Time to first passed flatus was
shorter by 1 day but not significantly so (median 1 day [1–
7 days] versus 2 days [1–6 days]; p = 0.091). Time to
solid food tolerance did not differ (4 days [2–11 days and
2–30 days, respectively]; p = 0.210).
Frequency of NGT reinsertion, postoperative vomiting,
and length of hospital stay did not differ significantly
between the groups (Table 3).
In the subgroup of laparoscopic resection with all con-
verted cases excluded, the results were similar to the main
collective. No significant difference in bisacodyl use
occurred (TEA 17, non-TEA 12; p = 0.799). Again, with
the exception of paracetamol (TEA mean 19.1 g [±1.0 g]
versus 14.1 g [±1.0 g]; p = 0.057), consumption of anal-
gesics was significantly lower in the TEA group. GI-
3 occurred significantly earlier. In this collective, time to
first flatus was also shorter by 1 day, but reached signifi-
cance (Table 4). Frequency of NGT reinsertion (TEA
n = 1 versus non-TEA n = 0, p = 1.000), postoperative
vomiting (TEA n = 6 versus non-TEA n = 5, p = 1.000)
and length of hospitalization (TEA n = 9 versus non-TEA
n = 11, p = 0.357) did not reach levels of significance.
Analysis of postoperative pain in this sub-group is shown
in Fig. 3.
Surgical and medical morbidity did not differ between
groups. Five patients (13%) in the TEA group had minor
TEA-related complications (Table 5). In one patient (3%)
the TEA had to be removed on postoperative day 1 (failure
of analgesic effect) and in three patients (8%) on postop-
erative day 2 (paresis of ipsilateral leg, hypotension). No
patient suffered from major TEA-related morbidity such as
epidural hematoma, abscess or nerve damage. No surgical
intervention for TEA related complications were necessary.
Discussion
Our study shows that TEA resulted in a significantly lower
analgesic consumption and lower VAS pain scores during
the observation period. Patients required less additional
Table 1 Patient characteristics and baseline data
TEA, n (%) Non-TEA, n (%) p value
Age* (years) 64.8 (2.0) 60.6 (2.3) 0.170
Males 18 (46.2) 23 (63.9) 0.165
Bisacodyl 21 (53.8) 15 (41.7) 0.358
Diagnosis
Cancer 2 (5.1) 3 (8.3) 1.000
Diverticulosis 33 (84.6) 30 (83.4) 0.557
Other 4 (10.3) 3 (8.3) 1.000
Type of surgery
Right hemicolectomy 2 (5.1) 1 (2.8) 1.000
Left hemicolectomy 3 (7.7) 0 0.241
Rectosigmoid resection 33 (84.6) 32 (88.9) 1.000
Anterior resection 0 1 (2.8) 0.480
Ileocecal resection 0 2 (5.5) 0.227
Segmental resection 1 (2.6) 0 1.000
Duration of surgery* (min) 176 (7.0) 180 (7.5) 0.046
Conversion 5 (12.8) 10 (27.8) 0.150
TEA = thoracic epidural analgesia
* mean [±SEM]
Table 2 Analgesics
consumption
TEA = thoracic epidural
analgesia
* median (range)
TEA, mean (SEM) Non-TEA, mean (SEM) p value
Metamizol (g)* 3.0 (0–32.0) 13.8 (0–28.0) \0.001
Opioids days 1–8 (mg) 12.2 (2.8) 103 (18.2) \0.001
Opioids days 1–4 (mg) 6.6 (1.8) 83.9 (13.8) \0.001
Opioids days 5–8 (mg) 5.6 (1.5) 17.6 (8.3) 0.162
Fig. 2 VAS pain scores [SEM] during the first eight postoperative
days
Table 3 Frequency of NGT reinsertion, vomiting, and length of
hospital stay
TEA, n
(%)
Non-TEA, n
(%)
p
value
Frequency of NGT reinsertion 3 (7.7) 2 (5.5) 1.000
Frequency of postoperative
vomiting
8 (20.5) 8 (22.2) 1.000
Length of hospital stay (days)* 11 (4–92) 11 (6–31) 0.665
TEA = thoracic epidural analgesia; NGT = nasogastric tube
* median (range)
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metamizol or opioids. The major effect was observed
during the first four postoperative days. The difference in
opioid consumption between the two groups was no longer
significant following TEA removal. Opioid consumption
remained constant in the TEA group after removal of the
epidural catheter, implying that TEA provides effective
analgesia without a rebound phenomenon after removal.
VAS pain scores were significantly lower during the first
three postoperative days and again on days 6 and 7. On
days 4 and 5 the figures did not reach significance, but only
by a narrow margin (p = 0.054 and p = 0.059, respec-
tively). VAS score on day 8 did not differ. Although the
catheter was removed on day 5, the analgesic benefit of
TEA seems to continue until day 7. The results for post-
operative pain relief in patients with laparoscopic
resections are inconsistent in the current literature and no
study has assessed the VAS pain scores beyond postoper-
ative day 4. Whereas Neudecker et al. were not able to
show any significant improved pain relief in a prospective
randomized trial with ten patients in each arm, two other
reports demonstrated better VAS scores during the first
48 hours in the TEA group [18–20]. The optimal duration
of TEA postoperatively is not well established. Some
authors suggest removal on the second postoperative day
[14, 21]. Senagore et al. removed the catheter 18 h post-
operatively and were unable to demonstrate a significant
effect on VAS pain scores after removal [19]. In the ran-
domized trial of Taqi et al., TEA was continued up to day
3, again showing no significant differences in pain per-
ception after removal [18].
According to the data in this study, the beneficial effect
of TEA persists up to postoperative day 7. Most patients,
especially the elderly, may not be discharged on the second
postoperative day but rather on day 5 or 6 , so that, pro-
viding daily clinical controls are present, TEA should be
left in place up to 5 days.
Return of gastrointestinal function was significantly
shorter in patients with TEA. This corresponds to the
findings of Senagore et al. and Taqi et al., who were able to
show an improved analgesia and earlier return of bowel
function in patients with TEA [17–19]. Incidence of NGT
reinsertion or postoperative vomiting did not differ
between the groups, which was surprising, as the non-TEA
group received a larger quantity of opioids. Liberal use of
anti-emetics (metoclopramide) for nausea may explain this
finding in this collective.
Length of hospital stay did not decrease in our study.
The median duration of 11 days is rather long compared
with the current literature, where 2–7 days are mentioned
[14, 16, 22]. The patients in this study were not enrolled in
a specific fast-track program. Factors such as waiting time
for subsequent stays in rehabilitation institutions or pro-
longation of hospitalization for social reasons may explain
this finding.
Current multimodal therapy programs for colorectal
surgery include TEA, avoidance or early removal of drains,
early oral feeding, and enforced mobilization [7, 15, 16,
Table 4 Subanalysis of patients with laparoscopically completed
procedures with exclusion of conversions (TEA: n = 34; Non-TEA:
n = 26)
TEA Non-TEA p value
Metamizol (g)* 5.4 (0–28) 12.6 (1–24.5) \0.001
Opioids days 1–8 (mg) 23.1 (4.5) 86.5 (22.3) 0.011
Opioids days 1–4 (mg) 16.9 (3.5) 68.1 (13.3) 0.001
Opioids days 5–8 (mg) 15.6 (1.5) 50.6 (8.3) 0.372
GI-3 2.8 (0.2) 4.0 (0.4) 0.017
Time to first solid food* 4 (2–11) 4 (2–30) 0.125
Time to first flatus passed* 1 (1–7) 2 (1–6) 0.016
Time to first stool 2.7 (0.3) 3.7 (0.3) 0.015
* median (range);  mean (SEM)
TEA = thoracic epidural analgesia
Fig. 3 Subgroup of laparoscopic resections with all converted cases
excluded. VAS pain scores [SEM] during the first eight postoperative
days
Table 5 Surgical, nonsurgical, and TEA-related morbidity
TEA,
n (%)
Non-TEA,
n (%)
p value
Surgical morbidity
Anastomotic leak 2 (5.1) 2 (5.5) 1.000
Deep surgical site infection 2 (5.1) 0 0.494
Superficial surgical site infection 1 (2.6) 3 (8.3) 0.345
Nonsurgical morbidity
Pneumonia 1 (2.6) 1 (2.8) 1.000
Urinary tract infection 0 1 (2.8) 0.480
TEA-related
Postoperative paresis 1 (2.6)
Hypotension 2 (5.1)
Paresthesia during insertion 2 (5.1)
TEA failure 1 (2.6)
TEA = thoracic epidural analgesia
280 Surg Endosc (2009) 23:276–282
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22]. As a single intervention, TEA has been shown to be
the most important factor in reducing postoperative ileus in
conventional surgery [9, 10]. As laparoscopic technique
leads to a decrease in pain, inflammatory reaction, and
postoperative ileus by itself, the question remains whether
TEA is needed at all [12, 13, 23, 24]. Morbidity from TEA
has to be considered. In the current study, minor compli-
cations occurred in five patients (13%). Paresis and
hypotension could be managed by removal of the TEA or,
in case of paresis during insertion, by repositioning of the
catheter. No major complications such as epidural hema-
toma, abscess or neurological damage occurred. The risk
for such complications is very small (0.01–0.7%) and the
benefit of TEA justifies its use [21, 25, 26]. The use of local
anesthetics (in this study duracain 0.125%) increases the
parasympathetic tone, thus accelerating gastrointestinal
recovery. The addition of the opioid fentanyl improves
analgesia. The combination of these two drugs has been
shown to be synergistic [3–5]. Thoracic application spares
the lumbar and sacral nerves so that motor and sensory
deficits (urinary retention, paralysis, hypotension) are
minimal.
The groups did not differ in surgical or medical mor-
bidity. Anastomotic leakage occurred in two patients in
each group. Consistent with other reports, continuous TEA
was not associated with an increased risk of anastomotic
leakage in this collective [27, 28].
To eliminate the influence of the converted cases, a
subanalysis of laparoscopically completed operations was
conducted. The results were similar to the main collective
and highlight the importance of TEA in laparoscopic
colorectal surgery. Patients without TEA consumed
overall less opioids than in the main collective. This is
explained by the fact that ten patients with conversion and
supposedly higher analgesics requirement were excluded
in this group. In the TEA group the trend was converse, a
fact we could not explain. However, only five patients
had conversion in this group and further analysis may not
be sensible. VAS pain scores were significantly lower in
the TEA group during the first 2 days and again on day 7.
No significance was reached during the other days, but a
clear trend towards lower pain levels in the TEA group is
shown.
This study is the largest analyzing the effect of TEA in
laparoscopic colorectal resection. Some limitations may be
discussed, including the fact that it is a subgroup analysis
of a larger randomized trial. A possible bias concerning
bisacodyl has been excluded, as there was no difference
between groups (p = 0.358). Postoperative systemic opi-
oid regimen in the non-TEA group was not standardized, as
a minority of patients received a PCA pump. However, the
amount of PCA morphine was monitored together with the
other opioids and equivalent total doses were calculated.
Conclusion
TEA in patients with laparoscopic colorectal resections
provides a significant benefit in terms of reduced use of
analgesics, lower VAS pain scores, and faster gastrointes-
tinal recovery with minimal morbidity. These results
support the use of TEA in minimal invasive colorectal
surgery and suggest that TEA has a positive analgesic
effect until postoperative day 7.
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